{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:05:52Z","timestamp":1785855952031,"version":"3.56.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04283-4","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:17:09Z","timestamp":1765901829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of clinicopathological and molecular characteristics of EBV-associated gastric cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Li","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anying","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"4283_CR1","doi-asserted-by":"crossref","unstructured":"Ferlay J, Colombet M, Soerjomataram I et al. Cancer statistics for the year 2020: an overview. Int J Cancer Published Online April 5, 2021.","DOI":"10.1002\/ijc.33588"},{"issue":"1","key":"4283_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13073-017-0484-3","volume":"9","author":"H Ichikawa","year":"2017","unstructured":"Ichikawa H, Nagahashi M, Shimada Y, et al. Actionable gene-based classification toward precision medicine in gastric cancer. Genome Med. 2017;9(1):93. Published 2017 Oct 31.","journal-title":"Genome Med"},{"issue":"4","key":"4283_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/cjp2.209","volume":"7","author":"H Tanabe","year":"2021","unstructured":"Tanabe H, Mizukami Y, Takei H, et al. Clinicopathological characteristics of Epstein-Barr virus and microsatellite instability subtypes of early gastric neoplasms classified by the Japanese and the world health organization criteria. J Pathol Clin Res. 2021;7(4):397\u2013409.","journal-title":"J Pathol Clin Res"},{"issue":"3","key":"4283_CR4","first-page":"377","volume":"3","author":"AP Burke","year":"1990","unstructured":"Burke AP, Yen TS, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990;3(3):377\u201380.","journal-title":"Mod Pathol"},{"issue":"10","key":"4283_CR5","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<1998::AID-CNCR6>3.0.CO;2-D","volume":"77","author":"H Matsunou","year":"1996","unstructured":"Matsunou H, Konishi F, Hori H, et al. Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer. 1996;77(10):1998\u20132004.","journal-title":"Cancer"},{"issue":"2","key":"4283_CR6","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4283_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10120-022-01351-4","volume":"26","author":"M Kanda","year":"2023","unstructured":"Kanda M, Terashima M, Kinoshita T, Yabusaki H, Tokunaga M, Kodera Y. A multi-institutional study to evaluate the feasibility of next-generation sequencing and genomic analysis using formalin-fixed, paraffin-embedded biopsies of gastric cancer. Gastric Cancer. 2023;26(1):108\u201315.","journal-title":"Gastric Cancer"},{"issue":"3","key":"4283_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/annonc\/mdv610","volume":"27","author":"BW Kang","year":"2016","unstructured":"Kang BW, Seo AN, Yoon S, et al. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer. Ann Oncol. 2016;27(3):494\u2013501.","journal-title":"Ann Oncol"},{"issue":"12","key":"4283_CR9","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1038\/bjc.2017.369","volume":"117","author":"AN Seo","year":"2017","unstructured":"Seo AN, Kang BW, Kwon OK, et al. Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer. Br J Cancer. 2017;117(12):1753\u201360.","journal-title":"Br J Cancer"},{"issue":"12","key":"4283_CR10","first-page":"p1431","volume":"37","author":"Z Lin","year":"2021","unstructured":"Lin Z, et al. Clinical and pathological analysis of 4 cases of EBV-Associated lymphoid interstitial gastric cancer. J Clin Experimental Pathol. 2021;37(12):p1431\u20131435.","journal-title":"J Clin Experimental Pathol"},{"issue":"9","key":"4283_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/microorganisms7090305","volume":"7","author":"A Yanagi","year":"2019","unstructured":"Yanagi A, Nishikawa J, Shimokuri K, et al. Clinicopathologic characteristics of Epstein-Barr Virus-Associated gastric cancer over the past decade in Japan. Microorganisms. 2019;7(9):305.","journal-title":"Microorganisms"},{"issue":"3","key":"4283_CR12","first-page":"543","volume":"12","author":"C Koriyama","year":"2004","unstructured":"Koriyama C, Akiba S, Corvalan A, et al. Histology-specific gender, age and tumor-location distributions of Epstein-Barr virus-associated gastric carcinoma in Japan. Oncol Rep. 2004;12(3):543\u20137.","journal-title":"Oncol Rep"},{"issue":"5","key":"4283_CR13","first-page":"657","volume":"8","author":"N Horiguchi","year":"2018","unstructured":"Horiguchi N, Tahara T, Kawamura T, et al. Unusual growth of an Epstein-Barr virus-associated differentiated early-stage gastric carcinoma: A case report. Mol Clin Oncol. 2018;8(5):657\u201360.","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"4283_CR14","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.21873\/anticanres.13328","volume":"39","author":"AN Seo","year":"2019","unstructured":"Seo AN, Kang BW, Bae HI, et al. Exon 9 mutation of PIK3CA associated with poor survival in patients with Epstein-Barr Virus-associated gastric cancer. Anticancer Res. 2019;39(4):2145\u201354.","journal-title":"Anticancer Res"},{"issue":"5","key":"4283_CR15","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1158\/1078-0432.CCR-05-2173","volume":"12","author":"W Qiu","year":"2006","unstructured":"Qiu W, Sch\u00f6nleben F, Li X, et al. PIK3CA mutations in head and neck squamous cell carcinoma. Clin Cancer Res. 2006;12(5):1441\u20136.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4283_CR16","doi-asserted-by":"publisher","first-page":"e0200343","DOI":"10.1371\/journal.pone.0200343","volume":"13","author":"H Blesinger","year":"2018","unstructured":"Blesinger H, Kaulfu\u00df S, Aung T, et al. PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations. PLoS ONE. 2018;13(7):e0200343.","journal-title":"PLoS ONE"},{"issue":"53","key":"4283_CR17","doi-asserted-by":"publisher","first-page":"90948","DOI":"10.18632\/oncotarget.18770","volume":"8","author":"JW Kim","year":"2017","unstructured":"Kim JW, Lee HS, Nam KH, et al. PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer. Oncotarget. 2017;8(53):90948\u201358.","journal-title":"Oncotarget"},{"issue":"2","key":"4283_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1349-7006.2007.00674.x","volume":"99","author":"S Akiba","year":"2008","unstructured":"Akiba S, Koriyama C, Herrera-Goepfert R, Eizuru Y. Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci. 2008;99(2):195\u2013201.","journal-title":"Cancer Sci"},{"issue":"1","key":"4283_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10120-018-0843-9","volume":"22","author":"A Kawazoe","year":"2019","unstructured":"Kawazoe A, Shitara K, Kuboki Y, et al. Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer. Gastric Cancer. 2019;22(1):69\u201376.","journal-title":"Gastric Cancer"},{"issue":"5","key":"4283_CR20","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/annonc\/mdx047","volume":"28","author":"C B\u00f6ger","year":"2017","unstructured":"B\u00f6ger C, Kr\u00fcger S, Behrens HM, et al. Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations. Ann Oncol. 2017;28(5):1005\u201314.","journal-title":"Ann Oncol"},{"issue":"1","key":"4283_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1158\/0008-5472.CAN-12-1726","volume":"73","author":"F Janku","year":"2013","unstructured":"Janku F, Wheler JJ, Naing A, et al. PIK3CA mutation H1047R is associated with response to PI3K\/AKT\/mTOR signaling pathway inhibitors in early-phase clinical trials. Cancer Res. 2013;73(1):276\u201384.","journal-title":"Cancer Res"},{"key":"4283_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.canlet.2020.09.019","volume":"495","author":"J Yang","year":"2020","unstructured":"Yang J, Liu Z, Zeng B, Hu G, Gan R. Epstein-Barr virus-associated gastric cancer: A distinct subtype. Cancer Lett. 2020;495:191\u20139.","journal-title":"Cancer Lett"},{"issue":"14","key":"4283_CR23","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.3748\/wjg.v20.i14.3927","volume":"20","author":"H Yamamoto","year":"2014","unstructured":"Yamamoto H, Watanabe Y, Maehata T, et al. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa. World J Gastroenterol. 2014;20(14):3927\u201337.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4283_CR24","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s43018-022-00382-1","volume":"3","author":"V Anagnostou","year":"2022","unstructured":"Anagnostou V, Bardelli A, Chan TA, Turajlic S. The status of tumor mutational burden and immunotherapy. Nat Cancer. 2022;3(6):652\u20136.","journal-title":"Nat Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04283-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04283-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04283-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T01:03:25Z","timestamp":1767661405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04283-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4283"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04283-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the retrospective nature of this study, the ethics committee of the hospital waived the informed consent of the patients and confirmed compliance with the Declaration of Helsinki and the confidentiality of the patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of the study and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}